These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10467264)

  • 1. In vitro neuroprotection against glutamate toxicity provided by novel non-competitive N-methyl-D-aspartate antagonists.
    Drian MJ; Kamenka JM; Privat A
    J Neurosci Res; 1999 Sep; 57(6):927-34. PubMed ID: 10467264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotoxicity of polyamines and pharmacological neuroprotection in cultures of rat cerebellar granule cells.
    Sparapani M; Dall'Olio R; Gandolfi O; Ciani E; Contestabile A
    Exp Neurol; 1997 Nov; 148(1):157-66. PubMed ID: 9398458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection by diphenyliodonium against glutamate neurotoxicity due to blocking of N-methyl-D-aspartate receptors.
    Nakamura Y; Tsuji K; Shuto M; Ogita K; Yoneda Y; Shimamoto K; Shibata T; Kataoka K
    Neuroscience; 1997 Jan; 76(2):459-66. PubMed ID: 9015330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamate receptor requirement for neuronal death from anoxia-reoxygenation: an in Vitro model for assessment of the neuroprotective effects of estrogens.
    Zaulyanov LL; Green PS; Simpkins JW
    Cell Mol Neurobiol; 1999 Dec; 19(6):705-18. PubMed ID: 10456232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors.
    Lea PM; Movsesyan VA; Faden AI
    Br J Pharmacol; 2005 Jun; 145(4):527-34. PubMed ID: 15821750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of glycine site NMDA receptor antagonists to protect against L-2-chloropropionic acid-induced neurotoxicity highlights the uniqueness of cerebellar NMDA receptors.
    Widdowson PS; Gyte AJ; Upton R; Wyatt I
    Brain Res; 1996 Nov; 738(2):236-42. PubMed ID: 8955518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imidazoline-induced neuroprotective effects result from blockade of NMDA receptor channels in neuronal cultures.
    Milhaud D; Fagni L; Bockaert J; Lafon-Cazal M
    Neuropharmacology; 2000 Sep; 39(12):2244-54. PubMed ID: 10974308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo antagonistic activities of SM-31900 for the NMDA receptor glycine-binding site.
    Ohtani K; Tanaka H; Yoneda Y; Yasuda H; Ito A; Nagata R; Nakamura M
    Brain Res; 2002 Jul; 944(1-2):165-73. PubMed ID: 12106676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. bFGF enhances the protective effects of MK-801 against ischemic neuronal injury in vitro.
    Barth A; Barth L; Morrison RS; Newell DW
    Neuroreport; 1996 Jun; 7(9):1461-4. PubMed ID: 8856698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of NMDA receptors protects against glutamate neurotoxicity in the retina: evidence for the involvement of neurotrophins.
    Rocha M; Martins RA; Linden R
    Brain Res; 1999 May; 827(1-2):79-92. PubMed ID: 10320696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylphenylpyridium ion (MPP+) enhances glutamate-induced cytotoxicity against dopaminergic neurons in cultured rat mesencephalon.
    Sawada H; Shimohama S; Tamura Y; Kawamura T; Akaike A; Kimura J
    J Neurosci Res; 1996 Jan; 43(1):55-62. PubMed ID: 8838574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide Y release from cultured hippocampal neurons: stimulation by glutamate acting at N-methyl-D-aspartate and AMPA receptors.
    Gemignani A; Marchese S; Fontana G; Raiteri M
    Neuroscience; 1997 Nov; 81(1):23-31. PubMed ID: 9300398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-Methyl-D-aspartate receptor antagonist MK-801 and radical scavengers protect cholinergic nucleus basalis neurons against beta-amyloid neurotoxicity.
    Harkany T; Mulder J; Sasvári M; Abrahám I; Kónya C; Zarándi M; Penke B; Luiten PG; Nyakas C
    Neurobiol Dis; 1999 Apr; 6(2):109-21. PubMed ID: 10343326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Derivatives of dexanabinol. II. Salts of amino acid esters containing tertiary and quaternary heterocyclic nitrogen with increased water-solubility.
    Pop E; Soti F; Brewster ME; Barenholz Y; Korablyov V; Mechoulam R; Nadler V; Biegon A
    Pharm Res; 1996 Mar; 13(3):469-75. PubMed ID: 8692744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative analysis of the neuroprotective properties of competitive and uncompetitive N-methyl-D-aspartate receptor antagonists in vivo: implications for the process of excitotoxic degeneration and its therapy.
    Massieu L; Thedinga KH; McVey M; Fagg GE
    Neuroscience; 1993 Aug; 55(4):883-92. PubMed ID: 7694181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of cultured rat cortical neurons from excitotoxicity by asarone, a major essential oil component in the rhizomes of Acorus gramineus.
    Cho J; Kim YH; Kong JY; Yang CH; Park CG
    Life Sci; 2002 Jun; 71(5):591-9. PubMed ID: 12052443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Domoic acid neurotoxicity in cultured cerebellar granule neurons is mediated predominantly by NMDA receptors that are activated as a consequence of excitatory amino acid release.
    Berman FW; Murray TF
    J Neurochem; 1997 Aug; 69(2):693-703. PubMed ID: 9231729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mGluR5 antagonists 2-methyl-6-(phenylethynyl)-pyridine and (E)-2-methyl-6-(2-phenylethenyl)-pyridine reduce traumatic neuronal injury in vitro and in vivo by antagonizing N-methyl-D-aspartate receptors.
    Movsesyan VA; O'Leary DM; Fan L; Bao W; Mullins PG; Knoblach SM; Faden AI
    J Pharmacol Exp Ther; 2001 Jan; 296(1):41-7. PubMed ID: 11123360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of inhibiting N-methyl-D-aspartate receptors, P2X receptors and the mitogen-activated protein kinase cascade: a quantitative analysis in organotypical hippocampal slice cultures subjected to oxygen and glucose deprivation.
    Rundén-Pran E; Tansø R; Haug FM; Ottersen OP; Ring A
    Neuroscience; 2005; 136(3):795-810. PubMed ID: 16344152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing conditions significantly attenuate the neuroprotective efficacy of competitive, but not other NMDA receptor antagonists in vitro.
    Pringle AK; Self J; Eshak M; Iannotti F
    Eur J Neurosci; 2000 Nov; 12(11):3833-42. PubMed ID: 11069578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.